| Year | Paper |
|---|---|
| 2008 | Baumgartner C, Gleixner KV, Peter B, Ferenc V, Gruze A, Remsing Rix LL, Bennett KL, Samorapoompichit P, Lee FY, Pickl WF, Esterbauer H, Sillaber C, Superti-Furga G, Valent P. Dasatinib inhibits the growth and survival of neoplastic human eosinophils (EOL-1) through targeting of FIP1L1–PDGFRalpha. Exp Hematol, 2008 Oct;36(10):1244–53. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18619723 |
| 2008 | Bergmark C, Dewan A, Orsoni A, Merki E, Miller ER, Shin MJ, Binder CJ, Hörkkö S, Krauss RM, Chapman MJ, Witztum JL, Tsimikas S. A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma. J Lipid Res. 2008, Oct;49(10):2230–9. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18594118 |
| 2008 | Binder CJ, Chou MY, Fogelstrand L, Hartvigsen K, Shaw PX, Boullier A, Witztum JL. Natural antibodies in murine atherosclerosis. Curr Drug Targets. 2008, Mar;9(3):190–5. Review. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18336236 |
| 2008 | Bro S, Flyvbjerg A, Binder CJ, Bang CA, Denner L, Olgaard K, Nielsen LB. A neutralizing antibody against receptor for advanced glycation end products (RAGE) reduces atherosclerosis in uremic mice. Atherosclerosis. 2008, Dec;201(2):274–80. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18371970 |
| 2008 | Bürckstümmer T, Bennett KL. Analysis of cellular protein complexes by affinity purification and mass spectrometry. In Proteomics Methods Express 2008 (O’Connor CD and Hames BD, eds.), pp 119–134, Scion, Oxfordshire. Abstract: |
| 2008 | Chou MY, Hartvigsen K, Hansen LF, Fogelstrand L, Shaw PX, Boullier A, Binder CJ, Witztum JL. Oxidation-specific epitopes are important targets of innate immunity. J Intern Med. 2008, May;263(5):479–88. Review. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18410591 |
| 2008 | De Keersmaecker K, Versele M, Cools J, Superti-Furga G, Hantschel O. Intrinsic differences between the catalytic properties of the oncogenic NUP214-ABL1 and BCRABL1 fusion protein kinases. Leukemia. 2008, Dec;22(12):2208–16. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18784740 |
| 2008 | Eggert US, Superti-Furga G. Drugs in Action. Nature Chem Biol, 2008 4(1):7–11. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18084271 |
| 2008 | Filippakopoulos P, Kofler M, Hantschel O, Gish GD, Grebien F, Salah E, Neudecker P, Kay LE, Turk BE, Superti-Furga G, Pawson T, Knapp S. Structural coupling of Fes and Abl SH2-tyrosine kinase domains links substrate recognition and kinase activation. Cell. 2008 Sep 5;134(5): 793–803. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18775312 |
| 2008 | Hantschel O, Gstoettenbauer A, Colinge J, Kaupe I, Bilban M, Burkard TR, Valent P, Superti-Furga G. The chemokine IL-8 and the surface activation protein CD69 are markers for Bcr-Abl activity in CML. Molecular Oncology, Vol 2/Issue3/ October 2008, 272–281. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19383348 |
| 2008 | Hantschel O, Rix U, Superti-Furga G. Target spectrum of the BCR-ABL inhibitors imatinib, nilotinib and dasatinib. Leuk Lymphoma, 2008 Apr;49(4):615-9. Review. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18398720 |
| 2008 | Henney A, Superti-Furga G. A network solution. Nature, 2008 Oct 9;455(7214):730–1. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18843342 |
| 2008 | Holzmann J, Frank P, Löffler E, Bennett KL, Gerner C and Rossmanith W. RNase P without RNA: Identification and Functional Reconstitution of the Human Mitochondrial tRNA Processing Enzyme. Cell 2008, Oct 31;135(3): 462–74. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18984158 |
| 2008 | Imai Y, Kuba K, Neely GG, Yaghubian-Malhami R, Perkmann T, van Loo G, Ermolaeva M, Veldhuizen R, Leung YH, Wang H, Liu H, Sun Y, Pasparakis M, Kopf M, Mech C, Bavari S, Peiris JS, Slutsky AS, Akira S, Hultqvist M, Holmdahl R, Nicholls J, Jiang C, Binder CJ, Penninger JM. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell. 2008, Apr 18;133(2):235–49. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18423196 |
| 2008 | Knapp S, von Aulock S, Leendertse M, Haslinger I, Draing C, Golenbock DT, van der Poll T. Lipoteichoic Acid-induced Lung Inflammation depends on TLR2 and the concerted action of TLR4 and Platelet-activating Factor Receptor. Journal of Immunology 2008, 180: 3478–3484. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18292574 |
| 2008 | Kneidinger M, Schmidt U, Rix U, Gleixner KV, Vales A, Baumgartner C, Lupinek C, Weghofer M, Bennett KL, Herrmann H, Schebesta A, Thomas WR, Vrtala S, Valenta R, Lee FY, Ellmeier W, Superti-Furga G, Valent P. The effects of dasatinib on IgE receptor-dependent activation and histamine release in human basophils. Blood, 2008 Jan 7; PMID: 18180381. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18180381 |
| 2008 | Kralovics R. Genetic complexity of myeloproliferative neoplasms. Leukemia. 2008 Oct;22(10):1841–8. Review. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18754034 |
| 2008 | Li S, Kralovics R, De Libero G, Theocharides A, Gisslinger H, Skoda RC. Clonal heterogeneity in polycythemia vera patients with JAK2 exon12 and JAK2-V617F mutations. Blood 2008, 111: 3863–3866. (abstract) Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18195094 |
| 2008 | Liu K, Kralovics R, Rudzki Z, Grabowska B, Buser AS, Olcaydu D, Gisslinger H, Tiedt R, Frank P, Okon K, Van der Maas APC and Skoda RC. A de novo splice donor mutation in the thrombopoietin gene causes hereditary thrombocythemia in a Polish family. Haematologica 2008, 93(5); 706–14. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18367486 |
| 2008 | Mathivanan S, Ahmed M, Ahn NG, Alexandre H, Amanchy R, Andrews PC, Bader JS, Balgley BM, Bantscheff M, Bennett KL, et al. Human Proteinpedia enables sharing of human protein data. Nature Biotech. 2008, 26, 164–167. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18259167 |
| 2008 | Mayerhofer M, Gleixner KV, Hoelbl A, Florian S, Hoermann G, Aichberger KJ, Bilban M, Esterbauer H, Krauth MT, Sperr WR, Longley JB, Kralovics R, Moriggl R, Zappulla J, Liblau RS, Schwarzinger I, Sexl V, Sillaber C, Valent P. Unique Effects of KIT D816V in BaF3 Cells: Induction of Cluster Formation, Histamine Synthesis, and Early Mast Cell Differentiation Antigens. The Journal of Immunology, 2008, 180: 5466–5476. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18390729 |
| 2008 | Nagano T, Mitchell JA, Sanz LA, Pauler FM*, Ferguson-Smith AC, Feil R, Fraser P. The Air noncoding RNA epigenetically silences transcription by targeting G9a to chromatin. Science 2008, Dec 12;322(5908):1717–20. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18988810 |
| 2008 | Pietra D, Li S, Brisci A, Passamonti F, Rumi E, Theocharides A, Ferrari M, Gisslinger H, Kralovics R, Cremonesi L, Skoda R, Cazzola M. Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders. Blood 2008, 111:1686–1689. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/17984312 |
| 2008 | Sämpi M, Ukkola O, Päivänsalo M, Kesäniemi YA, Binder CJ, Hörkkö S. Plasma interleukin – 5 levels are related to antibodies binding to oxidized low-density lipoprotein and to decreased subclinical atherosclerosis. J Am Coll Cardiol. 2008, Oct 21;52(17):1370–8. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18940525 |
| 2008 | Sharif O, Knapp S. From expression to signaling: Roles of TREM-1 and TREM-2 in innate immunity and bacterial infection. Immunobiology 2008, 213, 701–713. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18926286 |
| 2008 | Sherbenou DW, Hantschel O, Turaga L, Kaupe I, Willis S, Bumm T, Press RD, Superti-Furga G, Druker BJ, Deininger MW. Characterization of BCR-ABL deletion mutants from patients with chronic myeloid leukemia. Leukemia, 2008 Jun;22(6):1184–90. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18354488 |
| 2008 | Soulat D, Bürckstümmer T, Westermayer S, Goncalves A, Bauch A, Stefanovic A, Hantschel O, Bennett KL, Decker T, Superti-Furga G. The DEAD-box helicase DDX3 is a TBK1 substrate required for IFN-beta production. EMBO J, 2008 Aug 6;27(15):2135–46. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18583960 |
| 2008 | Stricker SH, Barlow DP, Latos PA. Size does matter: macro ncRNAs and the regulation of imprinted gene clusters. European Pharmaceutical Review 2008, Issue 1,10–17. Abstract: |
| 2008 | Stricker SH, Steenpass L, Pauler FM, Santoro F, Latos PA, Huang R, Koerner MV, Sloane MA, Warczok KE, Barlow DP. Silencing and transcriptional properties of the imprinted Airn ncRNA are independent of the endogenous promoter. The EMBO Journal 2008, 27, 3116–3128. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19008856 |
| 2008 | Superti-Furga G, Wieland F, Cesareni G. Finally: The digital, democratic age of scientific abstracts. FEBS Lett., 2008 Apr 9;582(8):1169. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18328821 |
| 2008 | Yotova IY, Vlatkovic IM, Pauler FM, Warczok KE, Ambros PF, Oshimura M, Theussl HC, Gessler M, Wagner EF, Barlow DP. Identification of the human homolog of the imprinted mouse Air non-coding RNA. Genomics 2008, Dec;92(6):464–73. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18789384 |